Acute angle closure glaucoma induced by selective serotonin reuptake inhibitor, and reversed by agomelatine
Agomelatine, a MT1 (Melatonin) and MT2 receptor agonist and 5-HT2C (5-Hidroksitriptamin) antagonist, is an antidepressant agent used in the treatment of major depressive disorders. Intraocular pressure lowering effect of melatonin and its analogues have been demonstrated in a few experimental studi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cukurova University
2019-12-01
|
| Series: | Cukurova Medical Journal |
| Subjects: | |
| Online Access: | https://dergipark.org.tr/tr/download/article-file/778048 |
| _version_ | 1828028976869670912 |
|---|---|
| author | Mehmet Emin Demirkol Mahmut Onur Karaytuğ Lut Tamam |
| author_facet | Mehmet Emin Demirkol Mahmut Onur Karaytuğ Lut Tamam |
| author_sort | Mehmet Emin Demirkol |
| collection | DOAJ |
| description | Agomelatine, a MT1 (Melatonin) and MT2 receptor agonist and 5-HT2C (5-Hidroksitriptamin) antagonist, is an antidepressant agent used in the treatment of major depressive disorders. Intraocular pressure lowering effect of melatonin and its analogues have been demonstrated in a few experimental studies. In the present case report, we have documented the reversal of angle closure glaucoma by oral agomelatine in a patient with major depressive disorder under selective serotonine reuptake inhibitor treatment. The patient, who had previously been diagnosed with glaucoma, was also receiving antiglaucomatous treatment. |
| first_indexed | 2024-04-10T14:03:02Z |
| format | Article |
| id | doaj.art-2f3ace2aa610484ca9fb02fecf8f2553 |
| institution | Directory Open Access Journal |
| issn | 2602-3040 |
| language | English |
| last_indexed | 2024-04-10T14:03:02Z |
| publishDate | 2019-12-01 |
| publisher | Cukurova University |
| record_format | Article |
| series | Cukurova Medical Journal |
| spelling | doaj.art-2f3ace2aa610484ca9fb02fecf8f25532023-02-15T16:10:11ZengCukurova UniversityCukurova Medical Journal2602-30402019-12-014441520152310.17826/cumj.57218648Acute angle closure glaucoma induced by selective serotonin reuptake inhibitor, and reversed by agomelatineMehmet Emin DemirkolMahmut Onur KaraytuğLut TamamAgomelatine, a MT1 (Melatonin) and MT2 receptor agonist and 5-HT2C (5-Hidroksitriptamin) antagonist, is an antidepressant agent used in the treatment of major depressive disorders. Intraocular pressure lowering effect of melatonin and its analogues have been demonstrated in a few experimental studies. In the present case report, we have documented the reversal of angle closure glaucoma by oral agomelatine in a patient with major depressive disorder under selective serotonine reuptake inhibitor treatment. The patient, who had previously been diagnosed with glaucoma, was also receiving antiglaucomatous treatment.https://dergipark.org.tr/tr/download/article-file/778048agomelatineangle closure glaucoma |
| spellingShingle | Mehmet Emin Demirkol Mahmut Onur Karaytuğ Lut Tamam Acute angle closure glaucoma induced by selective serotonin reuptake inhibitor, and reversed by agomelatine Cukurova Medical Journal agomelatine angle closure glaucoma |
| title | Acute angle closure glaucoma induced by selective serotonin reuptake inhibitor, and reversed by agomelatine |
| title_full | Acute angle closure glaucoma induced by selective serotonin reuptake inhibitor, and reversed by agomelatine |
| title_fullStr | Acute angle closure glaucoma induced by selective serotonin reuptake inhibitor, and reversed by agomelatine |
| title_full_unstemmed | Acute angle closure glaucoma induced by selective serotonin reuptake inhibitor, and reversed by agomelatine |
| title_short | Acute angle closure glaucoma induced by selective serotonin reuptake inhibitor, and reversed by agomelatine |
| title_sort | acute angle closure glaucoma induced by selective serotonin reuptake inhibitor and reversed by agomelatine |
| topic | agomelatine angle closure glaucoma |
| url | https://dergipark.org.tr/tr/download/article-file/778048 |
| work_keys_str_mv | AT mehmetemindemirkol acuteangleclosureglaucomainducedbyselectiveserotoninreuptakeinhibitorandreversedbyagomelatine AT mahmutonurkaraytug acuteangleclosureglaucomainducedbyselectiveserotoninreuptakeinhibitorandreversedbyagomelatine AT luttamam acuteangleclosureglaucomainducedbyselectiveserotoninreuptakeinhibitorandreversedbyagomelatine |